| Title |
Amphetamines for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2004
|
| DOI | 10.1002/14651858.cd004964 |
| Pubmed ID | |
| Authors |
Sue Nolte, David Wong, Gary Latchford, Owen Boyle, Adaeze Anaenugwu |
| Abstract |
It is estimated that between 10% and 65% of people with schizophrenia use illicit drugs such as amphetamines. This group have an increased rate of hospitalisation, homelessness, unemployment and suicide compared with those with schizophrenia who do not abuse drugs. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 38% |
| Australia | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 1 | <1% |
| Canada | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 135 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 17 | 12% |
| Student > Master | 16 | 12% |
| Researcher | 14 | 10% |
| Student > Ph. D. Student | 14 | 10% |
| Student > Doctoral Student | 12 | 9% |
| Other | 23 | 17% |
| Unknown | 42 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 28% |
| Psychology | 19 | 14% |
| Nursing and Health Professions | 11 | 8% |
| Social Sciences | 8 | 6% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Other | 12 | 9% |
| Unknown | 46 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2022.
All research outputs
#6,993,495
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,139
of 11,842 outputs
Outputs of similar age
#18,762
of 59,870 outputs
Outputs of similar age from Cochrane database of systematic reviews
#22
of 37 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 59,870 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.